In our weekly check, Gilead Sciences, Inc. is graded C (A to F). Of 19 checks on debt, profit, cash flow and trend: 10 pass, warnings: 2, red flags: 7.
Sector: Healthcare · Drug Manufacturers—General
Next earnings report: 2026-10-29
NVO · PFE · AMGN · AZN · BMY · NVS
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks graded D or F lost a third of their value 2-3 times as often as those graded A or B.
Updated 2026-10-03